Get the Stockscreener App
12.18
17.79%
1.84
Pre-market:
11.95
-0.23
-1.89%
Immatics N V stock is traded at $12.18, with a volume of 730.92K.
It is up +17.79% in the last 24 hours and up +31.68% over the past month.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
See More
Previous Close:
$10.34
Open:
$10.33
24h Volume:
730.92K
Relative Volume:
0.93
Market Cap:
$1.48B
Revenue:
$58.49M
Net Income/Loss:
$-105.04M
P/E Ratio:
-9.3714
EPS:
-1.2997
Net Cash Flow:
$-13.78M
1W Performance:
+14.80%
1M Performance:
+31.68%
6M Performance:
+111.83%
1Y Performance:
+52.82%
1-Day Range:
$9.98
$12.41
1-Week Range:
$9.76
$12.41
52-Week Range:
$3.30
$12.41
Immatics N V Stock (IMTX) Company Profile
Compare IMTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
12.18 | 1.26B | 58.49M | -105.04M | -13.78M | -1.2997 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Initiated | Guggenheim | Buy |
| May-28-25 | Initiated | Deutsche Bank | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Overweight |
| Nov-02-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-31-23 | Initiated | Mizuho | Buy |
| Mar-24-23 | Initiated | Bryan Garnier | Buy |
| Nov-20-20 | Initiated | BofA Securities | Buy |
| Sep-22-20 | Initiated | Goldman | Buy |
| Jul-27-20 | Initiated | SVB Leerink | Outperform |
| Jul-24-20 | Initiated | Jefferies | Buy |
View All
Immatics N V Stock (IMTX) Latest News
Immatics (NASDAQ:IMTX) Sets New 12-Month HighHere's What Happened - MarketBeat
How Immatics N.V. (4A3) stock compares with tech leaders2025 Bull vs Bear & Smart Allocation Stock Reports - Newser
Price-Driven Insight from (IMTX) for Rule-Based Strategy - news.stocktradersdaily.com
Is Immatics N.V. (4A3) stock included in top ETFsGold Moves & Short-Term Trading Alerts - Newser
Why pension funds invest in Immatics N.V. (4A3) stockWeekly Profit Recap & Weekly Watchlist of Top Performers - Newser
What dividend safety rating applies to Immatics N.V. (4A3) stockJuly 2025 WrapUp & Community Trade Idea Sharing Platform - Newser
Why Immatics N.V. (4A3) stock could rally stronglyJuly 2025 Recap & AI Enhanced Trading Alerts - Newser
Immatics (IMTX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Why Immatics N.V. Equity Warrant stock could outperform in 2025Weekly Earnings Recap & AI Enhanced Trading Signals - Newser
Is Immatics N.V. (4A3) stock a buy before new product rolloutIPO Watch & Free Fast Entry Momentum Trade Alerts - Newser
Why Immatics N.V. stock is considered a top pick2025 Risk Factors & Precise Buy Zone Identification - BỘ NỘI VỤ
Why Immatics N.V. stock is rated strong buy2025 Growth vs Value & High Win Rate Trade Tips - BỘ NỘI VỤ
Immatics Reports Q3 2025 Financial Results and Business Update - MSN
FY2025 EPS Estimates for Immatics Lowered by Chardan Capital - MarketBeat
How Rising Losses in the Latest Results Will Impact Immatics (IMTX) Investors - simplywall.st
Is Immatics N.V. (4A3) stock a top dividend aristocrat candidateJuly 2025 Selloffs & Weekly Chart Analysis and Guides - BỘ NỘI VỤ
How sustainable is Immatics N.V. stock dividend payoutGDP Growth & Weekly High Momentum Picks - BỘ NỘI VỤ
Views of Wall Street’s Leading Experts on Immatics N.V - Setenews
Immatics N.V. Reports Q3 2025 Financial Results and Progress - TipRanks
Chardan Capital Reaffirms Buy Rating for Immatics (NASDAQ:IMTX) - MarketBeat
Chardan Capital Maintains Immatics N.V. (IMTX) Buy Recommendation - Nasdaq
IMTX: Chardan Capital Maintains Buy Rating with $25 Target | IMT - GuruFocus
(IMTX) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Immatics FY2025 EPS Estimate Boosted by Cantor Fitzgerald - MarketBeat
Immatics FY2025 EPS Estimate Lifted by Cantor Fitzgerald - Defense World
FY2025 EPS Estimates for Immatics Boosted by Leerink Partnrs - MarketBeat
Will Immatics N.V. (4A3) stock return to pre crash levelsIPO Watch & Risk Controlled Swing Alerts - newser.com
Heatmap analysis for Immatics N.V. and competitorsJuly 2025 Volume & AI Driven Price Forecasts - newser.com
What macro factors could drive Immatics N.V. (4A3) stock higherBear Alert & Low Drawdown Momentum Ideas - newser.com
Immatics FY2025 EPS Estimate Increased by Leerink Partnrs - Defense World
Immatics (NASDAQ:IMTX) Given New $23.00 Price Target at Mizuho - MarketBeat
Will Immatics N.V. Equity Warrant stock maintain momentum in 2025July 2025 Earnings & AI Enhanced Market Trend Forecasts - newser.com
Immatics (IMTX) Reports Q3 Loss, Misses Revenue Estimates - MSN
What is the fair value of Immatics N.V. Equity Warrant stock nowWeekly Trade Report & Free High Accuracy Swing Entry Alerts - newser.com
How Immatics N.V. stock responds to policy changes2025 Buyback Activity & Consistent Profit Alerts - newser.com
Immatics (NASDAQ:IMTX) Price Target Raised to $19.00 at Guggenheim - Defense World
Why Immatics N.V. Equity Warrant stock remains a top recommendationAnalyst Downgrade & Low Risk Profit Maximizing Plans - newser.com
Will Immatics N.V. stock beat EPS estimatesTrade Exit Summary & Safe Capital Investment Plans - newser.com
Has Immatics N.V. Equity Warrant formed a bullish divergenceEarnings Miss & High Return Trade Opportunity Guides - newser.com
Mizuho Maintains Immatics N.V. (IMTX) Outperform Recommendation - Nasdaq
Why Immatics N.V. (4A3) stock appeals to dividend investorsJuly 2025 PostEarnings & Step-by-Step Swing Trade Plans - newser.com
Is Immatics N.V. Equity Warrant stock positioned for long term growthExit Point & AI Powered Buy/Sell Recommendations - newser.com
Will Immatics N.V. stock gain from strong economyWeekly Stock Recap & Low Drawdown Momentum Ideas - newser.com
Immatics (NASDAQ:IMTX) Shares Up 6.7% Following Analyst Upgrade - MarketBeat
A significant driver of top-line growth: Immatics N.V (IMTX) - Setenews
What analyst consensus says on Immatics N.V. stockStock Surge & Verified Short-Term Plans - newser.com
IMTX Stock Sees Raised Price Target by Mizuho Analyst | IMTX Sto - GuruFocus
Immatics N V Stock (IMTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):